"The Saudi Public Investment Fund (PIF) announced on Sunday "the launch of a commercial-scale contract development and manufacturing organization, Lifera, to help boost the local biopharmaceutical industry."" "I don't know that there are direct opportunities for small Amercian biotechs but I suspect there may be a review of some of the FDA's monolithic practices."
What do the purported FDA's monolithic practices have to do with the local Saudi American biopharmaceutical industry?
Can you not make ANY real connections involving IPIX to justify discussing this announcement?
News 
Market Data 
Discover 
